Trial record 1 of 1 for:    Phenylbutyrate Development for Huntington's Disease
Previous Study | Return to List | Next Study

Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)

This study has been completed.
Sponsor:
Collaborators:
HP Therapeutics Foundation
Massachusetts General Hospital
Columbia University
University of Iowa
University of California, San Diego
University of Kansas
University of Alabama at Birmingham
Johns Hopkins University
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00212316
First received: September 19, 2005
Last updated: August 14, 2012
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given